Company
Viridian Therapeutics, Inc.\DE
VRDN · CIK 0001590750
Sale of 4,212 shares at $24.50 per share.
Reporting Person Tousignant Jennifer · Officer Title Chief Legal Officer · Transaction Code S
Traded Aug 19, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001193125-26-359636 · filed 2026-08-20 · View filing →
Acquisition (code M) of 10,000 shares at $14.41 per share.
Reporting Person Tousignant Jennifer · Officer Title Chief Legal Officer · Transaction Code M
Traded Aug 19, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001193125-26-359636 · filed 2026-08-20 · View filing →
Sale of 10,000 shares at $24.50 per share.
Reporting Person Tousignant Jennifer · Officer Title Chief Legal Officer · Transaction Code S
Traded Aug 19, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001193125-26-359636 · filed 2026-08-20 · View filing →
Acquisition (code M) of 40,000 shares at $13.21 per share.
Reporting Person Tripuraneni Radhika · Officer Title Chief Medical Officer · Transaction Code M
Traded Aug 14, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0001193125-26-355735 · filed 2026-08-18 · View filing →